NIBR0213 [CAS 1233332-14-3]
Partner: MedChemexpress LLC
| CAS No: | 1233332-14-3 |
| Applications: | COVID-19-immunoregulation |
| MW: | 464.98 |
| Formula: | C27H29ClN2O3 |
| SMILES: | ClC1=CC=C([C@@H](C)NC2=CC=CC(C3=CC(C)=C(C(N[C@@H](C)C(O)=O)=O)C(C)=C3)=C2)C=C1C |
| Purity: | 99.0 |
| Description: | NIBR-0213 is a potent, orally active and selective S1P1�antagonist with efficacy in experimental autoimmune encephalomyelitis. NIBR-0213 displays potent and comparable potency on human and rat S1P1�(IC50�of 2.0�nM and 2.3�nM, respectively) in GTP?35S assays[1]. |
| Shipping Conditions: | Ship on cold packs |
| Usage: | Research Use Only |
Insight Biotechnology Ltd reserves the right to change pricing without notice
